111099 ⎘
ssRNA viruses negative-sense; Details; Rhabdoviridae; Lyssavirus, e.g. rabies virus Demonstrated effect
ARTIFICIAL NUCLEIC ACID MOLECULES FOR IMPROVED PROTEIN EXPRESSION
#2COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF RABIES VIRUS INFECTION
#3RABIES G PROTEIN AND USES THEREOF
#4GENE SHUFFLED LYSSAVIRUS VACCINE
#5ARTIFICIAL NUCLEIC ACID MOLECULES FOR IMPROVED PROTEIN EXPRESSION
#6VIRAL GUIDE RNA DELIVERY
#7CORONAVIRUS VACCINE COMPOSITIONS AND METHODS OF USE
#8METHODS OF TREATING OR PREVENTING A VIRAL INFECTION USING BACTERIOPHAGES
#9Artificial nucleic acid molecules for improved protein expression
#10CHIMPANZEE ADENOVIRUS CONSTRUCTS WITH LYSSAVIRUS ANTIGENS
#11Artificial nucleic acid molecules for improved protein expression
#12Artificial nucleic acid molecules for improved protein expression
#13CHIMPANZEE ADENOVIRUS CONSTRUCTS WITH LYSSAVIRUS ANTIGENS
#14Parainfluenza virus 5 based vaccines
#15Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
#16Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant
#17Human antibodies against rabies and uses thereof
#18Compositions and methods for treating viral infections
#19Canine adenovirus vectors
#20Artificial nucleic acid molecules for improved protein expression
#21RVG Derived peptides
#22PIV5 as an oncolytic agent
#23Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant
#24Parainfluenza virus 5 based vaccines
#25PHARMACEUTICAL COMPOSITION COMPRISING A POLYMERIC CARRIER CARGO COMPLEX AND AT LEAST ONE PROTEIN OR PEPTIDE ANTIGEN
#26PIV5 as oncolytic agent
#27COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS